Early Phase 1 Coeliac Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with celiac disease, confirmed by both a blood test and a small bowel (intestinal) biopsy
- You carry a specific gene type called HLA-DQ2.5, which is linked to celiac disease (confirm with trial site)
- You are currently following a strict gluten-free diet and it is well managed
- Your celiac-related blood test levels (specific antibodies) are within an acceptable low range (confirm exact values with trial site)
- You are female and are not currently pregnant or breastfeeding
- You do not have any other significant health issues found at your initial screening appointment
Who may not be able to join:
- Your celiac disease does not improve even when following a strict gluten-free diet (sometimes called "refractory" celiac disease)
- You have a condition where your body does not produce enough of a certain immune protein called IgA
- You carry a different gene type called HLA-DQ8 (confirm with trial site)
- You have a known allergy to wheat, including a serious allergic reaction type known as Type I hypersensitivity
- You currently have inflammatory bowel disease (such as Crohn's disease or ulcerative colitis) or another condition that causes symptoms similar to celiac disease
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Treatment Emergent Adverse Events, Serious Adverse Events and Adverse Events of Special Interest (AESIs); Changes from baseline and clinically significant abnormalities in standard Clinical Chemistry laboratory safety parameters; Changes from baseline and clinically significant abnormalities in standard Coagulation laboratory safety parameters; Changes from baseline and clinically significant abnormalities in standard hematology laboratory safety parameters; Changes from baseline and clinically significant abnormalities in standard urinalysis laboratory safety parameters; Changes from baseline...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.